Clinical Trial: A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822477) titled 'A Study to Investigate Safety, Tolerability and Pharmacokinetics of VH5356136 in Adult Participants Without HIV' on Sept. 10.

Brief Summary: The study aims to evaluate the safety, tolerability and pharmacokinetic (PK) properties of a single dose of VH5356136 in adult participants without human immunodeficiency virus (HIV). This study will be conducted following the availability of initial safety and PK clinical data from formulation of the parent drug VH4524184.

Study Start Date: Nov. 06

Study Type: INTERVENTIONAL

Condition: HIV Infections

Intervention: DRUG: VH5356136 Formulation 1

Participants will receive VH5356136 Formul...